Cover Image
Market Research Report

Europe Autoimmune Disease Therapeutics Market (2019-2025)

Published by KBV Research Product code 906235
Published Content info 106 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Autoimmune Disease Therapeutics Market (2019-2025)
Published: July 31, 2019 Content info: 106 Pages
Description

The Europe Autoimmune Disease Therapeutics Market would witness market growth of 3.94% CAGR during the forecast period (2019-2025).

Epigenetic pathways play a key role in the growth and function of the immune system. A growing body of research has been released over the past century attempting to clarify the correlation between epigenetic modifications and the growth of autoimmune disorders. Epigenetic changes like histone modifications, DNA methylation, and non-coding RNAs, are primarily engaged in the pathogenesis of autoimmune diseases by controlling gene expression. Significant epigenetic changes have occurred during the growth of the most common human autoimmune diseases. These changes include systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjogren's syndrome (SS), autoimmune thyroid illnesses (AITD), and type 1 diabetes (T1D). These targeted at offering fresh insights into the pathogenesis of autoimmune diseases and the chance of developing new therapeutic strategies that target the epigenome.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

Scope of the Study

Market Segmentation:

By Indication

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications

By Drug Class

  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled:

  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Autoimmune Disease Therapeutics Market, by Indication
    • 1.4.2 Europe Autoimmune Disease Therapeutics Market, by Drug Class
    • 1.4.3 Europe Autoimmune Disease Therapeutics Market, by Distribution Channel
    • 1.4.4 Global Autoimmune Disease Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Autoimmune Disease Therapeutics Market by Indication

  • 3.1 Europe Rheumatic Disease Market by Country
  • 3.2 Europe Diabetes Market by Country
  • 3.3 Europe Multiple Sclerosis Market by Country
  • 3.4 Europe Inflammatory Bowel Disease Market by Country
  • 3.5 Europe Other Indications Market by Country

Chapter 4. Europe Autoimmune Disease Therapeutics Market by Drug Class

  • 4.1 Europe Anti-Inflammatory Market by Country
  • 4.2 Europe Anti-Hyperglycemics Market by Country
  • 4.3 Europe NSAIDs Market by Country
  • 4.4 Europe Interferons Market by Country
  • 4.5 Europe Other Drugs Market by Country

Chapter 5. Europe Autoimmune Disease Therapeutics Market by Distribution Channel

  • 5.1 Europe Hospital Pharmacy Market by Country
  • 5.2 Europe Online Market by Country
  • 5.3 Europe Retail Pharmacies and Drug Stores Market by Country

Chapter 6. Europe Autoimmune Disease Therapeutics Market by Country

  • 6.1 Germany Autoimmune Disease Therapeutics Market
    • 6.1.1 Germany Autoimmune Disease Therapeutics Market by Indication
    • 6.1.2 Germany Autoimmune Disease Therapeutics Market by Drug Class
    • 6.1.3 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.2 UK Autoimmune Disease Therapeutics Market
    • 6.2.1 UK Autoimmune Disease Therapeutics Market by Indication
    • 6.2.2 UK Autoimmune Disease Therapeutics Market by Drug Class
    • 6.2.3 UK Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.3 France Autoimmune Disease Therapeutics Market
    • 6.3.1 France Autoimmune Disease Therapeutics Market by Indication
    • 6.3.2 France Autoimmune Disease Therapeutics Market by Drug Class
    • 6.3.3 France Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.4 Russia Autoimmune Disease Therapeutics Market
    • 6.4.1 Russia Autoimmune Disease Therapeutics Market by Indication
    • 6.4.2 Russia Autoimmune Disease Therapeutics Market by Drug Class
    • 6.4.3 Russia Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.5 Spain Autoimmune Disease Therapeutics Market
    • 6.5.1 Spain Autoimmune Disease Therapeutics Market by Indication
    • 6.5.2 Spain Autoimmune Disease Therapeutics Market by Drug Class
    • 6.5.3 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.6 Italy Autoimmune Disease Therapeutics Market
    • 6.6.1 Italy Autoimmune Disease Therapeutics Market by Indication
    • 6.6.2 Italy Autoimmune Disease Therapeutics Market by Drug Class
    • 6.6.3 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.7 Rest of Europe Autoimmune Disease Therapeutics Market
    • 6.7.1 Rest of Europe Autoimmune Disease Therapeutics Market by Indication
    • 6.7.2 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
    • 6.7.3 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 ABBOTT Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Bio-Rad Laboratories, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Johnson and Johnson
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental &Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.1 Recent strategies and developments:
      • 7.3.1.1 Collaborations, partnerships and agreements:
  • 7.4 GlaxoSmithKline PLC (GSK)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Acquisition and mergers:
      • 7.4.5.2 Collaborations, partnerships and agreements:
      • 7.4.5.3 Product launches:
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Collaborations, partnerships and agreements:
      • 7.5.5.2 Approval:
  • 7.6 Merck & Co., Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Bayer AG (Bayer Schering Pharma AG)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Collaborations, partnerships and agreements:
  • 7.8 AbbVie, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
  • 7.9 Amgen, Inc.
    • 7.9.1 Company overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Product launches:
      • 7.9.5.2 Collaborations, partnerships and agreements:
  • 7.1 Novartis AG
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Acquisition and mergers:
      • 7.10.5.2 Collaborations, partnerships and agreements:

LIST OF TABLES

  • TABLE 1 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 4 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 5 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 EUROPE RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 EUROPE DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 EUROPE DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 EUROPE INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 EUROPE OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 16 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 17 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 18 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 19 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 EUROPE ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 EUROPE NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 EUROPE NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 EUROPE INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 24 EUROPE INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 25 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 26 EUROPE OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 27 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 28 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 29 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 30 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 31 EUROPE ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 32 EUROPE ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 33 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 34 EUROPE RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 35 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 36 EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 37 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 38 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 39 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 40 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 41 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 42 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 43 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 44 GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 45 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 46 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 47 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 48 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 49 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 50 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 51 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 52 UK AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 53 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 56 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 57 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 58 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 59 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 60 FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 61 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 62 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 63 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 64 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 65 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 66 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 67 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 68 RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 69 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 70 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 71 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 72 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 73 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 74 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 75 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 76 SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 77 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 78 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 79 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 80 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 81 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 82 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 83 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 84 ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 85 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 86 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 87 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 88 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 89 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 90 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 91 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 92 REST OF EUROPE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 93 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 94 KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 95 KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 96 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 97 KEY INFORMATION - PFIZER, INC.
  • TABLE 98 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 99 KEY INFORMATION - BAYER AG
  • TABLE 100 KEY INFORMATION - ABBVIE, INC.
  • TABLE 101 KEY INFORMATION - AMGEN, INC.
  • TABLE 102 KEY INFORMATION - NOVARTIS AG

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top